Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 7Vulvar Neoplasms 1Vaginal Neoplasms 1Vaginal Atrophy 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Metastatic Breastcancer 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Depression 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1Atrophic Vaginitis 1Anxiety Disorders 1

Interventions

Psychiatric Rehabilitation 5Music Therapy 5Cognitive Behavioral Therapy 4Yoga 3Therapeutics 3Surveys and Questionnaires 3Saline Solution 3Mindfulness-Based Cognitive Therapy 3Mindfulness 3Methods 3Esketamine 3Standard of Care 2Mindfulness-Based Stress Reduction 2Hypnosis 2Educational Status 2Early Intervention, Educational 2Counseling 2Acupuncture Therapy 2Acceptance and Commitment Therapy 2Virtual Reality Exposure Therapy 1Self-Management 1Self-Help Groups 1Psychosocial Intervention 1Professional Autonomy 1Postoperative Period 1Population Groups 1Neoadjuvant Therapy 1Minocycline 1Melatonin 1Massage 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anxiety Disorders × Dehydroepiandrosterone × Breast × Clear all
NCT01376349 2019-02-07

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Alliance for Clinical Trials in Oncology

Phase 3 Completed
464 enrolled 8 charts
BreastGynecologicOther

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Sexual Dysfunction, Physiological, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡